Philip Scheltens
InvestorPartner at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M – $65M checks · typically $25M
About
Philip Scheltens is Partner and Head of the Dementia Fund at EQT Life Sciences, having joined as a Partner at LSP in 2021 before LSP merged with EQT. Before that, he served as Director of the Alzheimer Center at Amsterdam University Medical Center. He is an MD in neurology with a PhD in Medicine from VU University Amsterdam and is Professor of Neurology at Amsterdam University Medical Center.
Invests in
Biotech
Experience
- BioArcticMember of The Supervisory Boardcurrent2026 — presentStockholm, Stockholm County, Sweden
- EXCIVA GmbHBoard Membercurrent2025 — presentMunich, Bavaria, Germany
- AstronauTxBoard Membercurrent2024 — presentLondon Area, United Kingdom
- NobiBoard Membercurrent2023 — presentAntwerp, Flemish Region, Belgium
- EQT GroupPartnercurrent2023 — presentAmsterdam, North Holland, Netherlands
- EQT Life SciencesHead Dementia Fundcurrent2022 — presentAmsterdam
- AviadoBioBoard Observercurrent2022 — presentLondon Area, United Kingdom
- King's College LondonVisiting Professor of Neurologycurrent2021 — presentGreater London, England, United Kingdom
- VU University Medical CenterEmeritus Professor of Cognitive Neurologycurrent2000 — present
- Amsterdam UMC - Alzheimer Center AmsterdamNeurologist1991 — 2023Amsterdam, North Holland, Netherlands
- Amsterdam UMC - Alzheimer Center AmsterdamDirector2000 — 2022Amsterdam, North Holland, Netherlands
- LSPManaging Partner2020 — 2022Amsterdam Area
- University College LondonHonorary Professor2008 — 2021
- KNAW - Koninklijke Nederlandse Akademie van WetenschappenMember of the Board2015 — 2020The Randstad, Netherlands
- Parelsnoer InstituteScientific Director2011 — 2015Amsterdam
- VU University Medical Center - Neuroscience Campus AmsterdamStaff Member1991 — 2000The Randstad, Netherlands
- VU University Medical Center - Neuroscience Campus AmsterdamResident Physician1986 — 1991The Randstad, Netherlands
- SlotervaartziekenhuisResident in Neurosurgery1986
Skills & more
Public Health21Neuroscience74Healthcare62Clinical Research52Teaching5Research15Science19Lifesciences12Genetics4Pharmacology5Immunology6Clinical Trials18
+12 more
Alzheimer's diseaseBiotechnologyCell BiologyEpidemiologyHospitalsMedical EducationMedicineMolecular BiologyOncologyLife SciencesInternal MedicineMedical ResearchLanguages English
From Philip's professional profile.
Colleagues at EQT Life Sciences
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Frequently asked questions
- Who is Philip Scheltens?
- Philip Scheltens is Partner and Head of the Dementia Fund at EQT Life Sciences, having joined as a Partner at LSP in 2021 before LSP merged with EQT. Before that, he served as Director of the Alzheimer Center at Amsterdam University Medical Center. He is an MD in neurology with a PhD in Medicine from VU University Amsterdam and is Professor of Neurology at Amsterdam University Medical Center.
- Where does Philip Scheltens work?
- Philip Scheltens is Partner at EQT Life Sciences.
- What does Philip Scheltens invest in?
- Philip Scheltens invests in Biotech.
- What check size does Philip Scheltens write?
- Philip Scheltens typically writes checks of $11M – $65M.
- Where did Philip Scheltens go to school?
- Philip Scheltens studied at Vrije Universiteit Amsterdam (VU Amsterdam) (MD, Medicine).
Same school
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)149
Brendan Bulik-SullivanInvestor at GV (Google Ventures)Kyang YungInvestor at DaphniJohann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersMercedes TuinPartner at Heran PartnersProf. Dr. Jan Peter BalkenendeVoorzitter at Noaber
+ 143 more
Shared employers
Also worked at EXCIVA GmbH4
Also worked at Nobi7
Rudy DekeyserPartner, Head of Health Economic Funds at EQT Life SciencesTanja DoweManaging Director at Angelini VenturesPatrick GrissCEO Ventures and Partner at Zühlke VenturesRoeland PelgrimsVenture Partner at RDY VenturesArno de WildeInvestor at EQT Life SciencesSonia HallenVice President at EQT Life Sciences
+ 1 more
Also worked at VU University Medical Center16
René KuijtenInvestor at LSP (Life Sciences Partners)René R. KuijtenInvestor at LSP (Life Sciences Partners)Mercedes TuinPartner at Heran PartnersTherese LiechtensteinPartner at 4BIO CapitalMercedes TuinInvestment Director at BOMRené KuijtenPartner, Head of EQT Life Sciences at EQT Life Sciences
+ 10 more
Also worked at LSP14
Drew BurdonInvestor at LSP (Life Sciences Partners)Anna BellmuntSenior Associate at Asabys PartnersRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalJoachim RothePartner at EQT Life SciencesFouad AzzamPartner at EQT Life SciencesJohn de KoningPartner at EQT Life Sciences
+ 8 more












































